Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results83% success

Data Visualizations

Phase Distribution

4Total

Not Applicable (3)

P 3 (1)

Trial Status

Completed5

Unknown3

Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07442110CompletedPrimary

This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

NCT04410042Phase 3Terminated

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

NCT05223283CompletedPrimary

Limb Salvage Post Venous Injury:Case Series

NCT02536053CompletedPrimary

Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage

NCT03107728Not ApplicableUnknownPrimary

The IM ABLE Study: A Study of Warriors & Veterans Following Neuromusculoskeletal Injury of the Lower Limb

NCT03521258Not ApplicableUnknown

Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane

NCT02372838CompletedPrimary

Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap